| Literature DB >> 30783371 |
Li-Qiang Zhou1, Jia-Yu Wang1, Song-Yuan Yu2, Ge-Ge Wu1, Qi Wei1, You-Bin Deng1, Xing-Long Wu3, Xin-Wu Cui4, Christoph F Dietrich1.
Abstract
Artificial intelligence (AI), particularly deep learning algorithms, is gaining extensive attention for its excellent performance in image-recognition tasks. They can automatically make a quantitative assessment of complex medical image characteristics and achieve an increased accuracy for diagnosis with higher efficiency. AI is widely used and getting increasingly popular in the medical imaging of the liver, including radiology, ultrasound, and nuclear medicine. AI can assist physicians to make more accurate and reproductive imaging diagnosis and also reduce the physicians' workload. This article illustrates basic technical knowledge about AI, including traditional machine learning and deep learning algorithms, especially convolutional neural networks, and their clinical application in the medical imaging of liver diseases, such as detecting and evaluating focal liver lesions, facilitating treatment, and predicting liver treatment response. We conclude that machine-assisted medical services will be a promising solution for future liver medical care. Lastly, we discuss the challenges and future directions of clinical application of deep learning techniques.Entities:
Keywords: Artificial intelligence; Deep learning; Imaging; Liver; Machine learning; Ultrasound
Mesh:
Year: 2019 PMID: 30783371 PMCID: PMC6378542 DOI: 10.3748/wjg.v25.i6.672
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Clinical application of artificial intelligence
| 1 | Detecting fatty liver disease and making risk stratification | Deep learning based on US | 100% | 100% | 100% | [ |
| 2 | Detecting and distinguishing different focal liver lesions | Deep learning based on US | 97.2% | 98% | 95.7% | [ |
| 3 | Evaluating liver steatosis | Deep learning based on US | 96.3% | 100% | 88.2% | [ |
| 4 | Evaluating chronic liver disease | Machine learning algorithm based on SWE | 87.3% | 93.5% | 81.2% | [ |
| 5 | Discriminating liver tumors | DCCA-MKL framework based on US | 90.41% | 93.56% | 86.89% | [ |
| 6 | Predicting treatment response | Machine learning algorithm based on MRI | 78% | 62.5% | 82.1% | [ |
DCCA-MKL: Deep canonical correlation analysis-multiple kernel learning; MRI: Magnetic resonance imaging; US: Ultrasound.
Liver leision detection
| 1 | Detecting liver new tumors | Deep learning based on CT | 86% | [ |
| 2 | Predicting the primary origin of liver metastasis | Deep learning based on CT | 56% | [ |
| 3 | Detecting cirrhosis with liver capsules | Deep learning based on ultrasound | 96.8% | [ |
| 4 | Detecting fatty liver disease and making risk stratification | Deep learning based on ultrasound | 100% | [ |
| 5 | Detecting and distinguishing different focal liver lesions. | Deep learning based on ultrasound | 97.2% | [ |
| 6 | Detecting metastatic liver malignancy | Deep learning based on PET/CT | 90.5% | [ |
CT: Computed tomography; PET: Positron emission tomography.
Diffuse liver disease staging
| 1 | Deep learning based on MRI | F4: 0.84; ≥ F3: 0.84; ≥ F2: 0.85 | [ |
| 2 | Deep learning based on CT | F4: 0.73; ≥ F3: 0.76; ≥ F2: 0.74 | [ |
| 3 | Deep learning based on SWE | F4: 0.97; ≥ F3: 0.98; ≥ F2: 0.85 | [ |
AUC: Area under the receiver operating characteristic curve; MRI: Magnetic resonance imaging; CT: Computed tomography; SWE: Shear wave elastography.